HomeScience NewsClinical Oncology Next-Generation Sequencing Market: Global Industry Analysis and Forecast (2024-2030)

Clinical Oncology Next-Generation Sequencing Market: Global Industry Analysis and Forecast (2024-2030)

Clinical Oncology Next-Generation Sequencing Market size was valued at USD 9.49 Billion in 2023 and the total Clinical Oncology Next-Generation Sequencing revenue is expected to grow at a CAGR of 20.7 % from 2024 to 2030, reaching nearly USD 35.42 Billion by 2030.

Clinical Oncology Next-Generation Sequencing Market Report Overview

The analysis examines current and future conditions in the Clinical Oncology Next-Generation Sequencing Market, giving unique insights and up-to-date data across major segments. The report includes crucial research topics in the Clinical Oncology Next-Generation Sequencing market, including revenue generation, sales, and overall income. To offer a comprehensive perspective, the report covers two separate scenarios that cover the whole Clinical Oncology Next-Generation Sequencing market, including estimated Clinical Oncology Next-Generation Sequencing sales during the forecast period.

Explore additional details by clicking the link provided: https://www.maximizemarketresearch.com/request-sample/100383 

Clinical Oncology Next-Generation Sequencing Market Report Scope and Research Methodology:

The primary purpose of the Clinical Oncology Next-Generation Sequencing market study is to provide a thorough analysis in clear and simple terms. The analysis covers all of the major companies and essential features of the Clinical Oncology Next-Generation Sequencing market, assessing numerous metrics such as volume, share, growth, and strategy. This research not only helps established organisations refine their operating plans, but it also provides strategic recommendations to new entrants. MMR’s research delves deeply into the Clinical Oncology Next-Generation Sequencing market, identifying the leading worldwide businesses based on parameters such as volume, share, strategies, and growth. The research also includes tactics for both existing industry participants and potential Clinical Oncology Next-Generation Sequencing market entrants. Furthermore, the global research for the Clinical Oncology Next-Generation Sequencing market provides a detailed breakdown of regional share distribution, as well as an examination of development drivers in each area.

Market Dynamics:

Rising global cancer burden boosts demand for precise genomic analysis, propelling clinical oncology next-generation sequencing market growth.

Continuous improvements in NGS technology are boosting the Clinical Oncology Next-Generation Sequencing Market. For example, Illumina’s NovaSeq platform will revolutionise cancer genome analysis by increasing sequencing speed and accuracy. This innovation propels market expansion by allowing for speedy and cost-effective genomic profiling in oncology research and clinical applications. The rising worldwide cancer burden, particularly in emerging countries, increases the need for accurate genomic analysis afforded by NGS. Thermo Fisher’s Oncomine tests, which provide full molecular profile, address this requirement by facilitating targeted therapy selection and monitoring, hence accelerating market expansion amid escalating cancer incidence estimates.

Clinical Oncology Next-Generation Sequencing Market Segmentation:

by Technology
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Others

by Workflow
Pre-Sequencing
Sequencing
Data Analysis

Based on technology, Whole Genome Sequencing dominated the Clinical Oncology Next-Generation Sequencing Market in 2023. It provides a comprehensive view of an individual’s entire genome, allowing for the identification of novel mutations and complex structural variations, but its adoption is hampered by high costs and extensive data analysis. Whole Exome Sequencing (WES) focuses on sequencing the genome’s protein-coding regions, providing a balance of cost-effectiveness and extensive genomic coverage, making it ideal for finding cancer-related coding mutations. Targeted Sequencing, on the other hand, selectively reads specific regions of interest, resulting in excellent sensitivity and cost efficiency, especially when discovering known cancer-associated mutations.

Curious about the content? Explore a sample copy of this report

Clinical Oncology Next-Generation Sequencing Market Regional Insights:

North America stands out as the leading region in the Clinical Oncology Next-Generation Sequencing (NGS) market, owing to several key factors. The region’s dominance is underscored by regulatory initiatives in the United States aimed at enhancing cancer screening diagnoses, such as the Cancer Genome Atlas program by the National Cancer Institute (NCI), which has conducted NGS on over 20,000 cancer samples from various forms of the disease. This regulatory focus on early detection and diagnosis fuels demand for clinical oncology NGS platforms. Moreover, the region witnesses a surge in the use of sequencing platforms for clinical diagnosis, facilitated by the declining costs of installation. The accessibility of genomic and proteomic data contributes to the market’s growth trajectory, presenting opportunities for further expansion in the foreseeable future.

Clinical Oncology Next-Generation Sequencing Market Key Players:

Major Contributors in the Clinical Oncology Next-Generation Sequencing Industry in North America:
1. Illumina, Inc.., San Diego, California, USA
2. Thermo Fisher Scientific, Inc., Waltham, Massachusetts, USA
3. Guardant Health, Inc., Redwood City, California, USA
4. PPacific Bioscience of California, Inc., Menlo Park, California, USA
5. Agilent Technologies, Inc., Santa Clara, California, USA
Leading players in the Europe Clinical Oncology Next-Generation Sequencing Market:
1. Qiagen N.V., Venlo, Netherlands
2. Roche Holdings AG (including Foundation Medicine), Basel, Switzerland
3. Oxford Nanopore Technologies Ltd., Oxford, United Kingdom
4. Genewiz Germany GmbH, Leipzig, Germany
5. Sophia Genetics SA, Saint-Sulpice, Switzerland
Key players driving the Asia-Pacific Clinical Oncology Next-Generation Sequencing Market:
1. Novogene Corporation, Beijing, China
2. BGI Group, Shenzhen, China
3. Takara Bio Inc., Kusatsu, Japan
4. MedGenome Labs Pvt. Ltd., Bengaluru, India

To dive into the specifics, click the below link: https://www.maximizemarketresearch.com/request-sample/100383 

Table of Content: Clinical Oncology Next-Generation Sequencing Market

Part 01: Executive Summary

Part 02: Scope of the Clinical Oncology Next-Generation Sequencing Market Report

Part 03: Clinical Oncology Next-Generation Sequencing Market Landscape

Part 04: Clinical Oncology Next-Generation Sequencing Market Sizing

Part 05: Clinical Oncology Next-Generation Sequencing Market Segmentation by Type

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Key Offerings:

  • Past Market Size and Competitive Landscape (2023-2029)
  • Past Pricing and price curve by region (2023-2029)
  • Market Size, Share, Size Forecast by different segment | 2024-2030
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
  • Market Segmentation – A detailed analysis by segments and their sub-segments
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective
    • Competitive landscape – Market Leaders, Market Followers, Regional player
    • Competitive benchmarking of key players by region
  • PESTLE Analysis
  • PORTER’s analysis
  • Value chain and supply chain analysis
  • Legal Aspects of business by region
  • Lucrative business opportunities with SWOT analysis
  • Recommendations

Read Full Report: https://www.maximizemarketresearch.com/market-report/clinical-oncology-next-generation-sequencing-market/100383/ 

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

sales@maximizemarketresearch.com

+91 96071 95908, +91 9607365656

Our Top Related Reports:

Global Phototherapy Equipment Market https://www.maximizemarketresearch.com/market-report/global-phototherapy-equipment-market/25598/ 
Global Blood Preparation Market https://www.maximizemarketresearch.com/market-report/global-blood-preparation-market/10842/